4//SEC Filing
Cummings Keith Lamont 4
Accession 0001746473-24-000115
CIK 0001746473other
Filed
Jul 10, 8:00 PM ET
Accepted
Jul 11, 4:54 PM ET
Size
5.1 KB
Accession
0001746473-24-000115
Insider Transaction Report
Form 4
Cummings Keith Lamont
Chief Financial Officer
Transactions
- Award
Common Stock
2024-07-09+21,313→ 293,026 total
Footnotes (1)
- [F1]On July 28, 2022, the Reporting Person was granted 77,500 performance-vested stock units, the vesting of which were subject to the achievement of various pre-established performance criteria. On July 9, 2024, the Compensation Committee of the Issuer's Board of Directors certified the achievement of the performance criteria tied to the company's total shareholder return relative to the Nasdaq Biotechnology Index, resulting in the vesting of 21,313 shares.
Documents
Issuer
PLIANT THERAPEUTICS, INC.
CIK 0001746473
Entity typeother
Related Parties
1- filerCIK 0001809204
Filing Metadata
- Form type
- 4
- Filed
- Jul 10, 8:00 PM ET
- Accepted
- Jul 11, 4:54 PM ET
- Size
- 5.1 KB